Maprotiline
Therapeutic agent (verify pharmacological class)
What it is used for
Therapeutic use is agent- and indication-specific within the class (Therapeutic agent (verify pharmacological class)). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Depressive illness
Warnings
Blood monitoring; history of epilepsy; pregnancy and lactation; history of mania; close angle glaucoma; concurrent electroconvulsive therapy; anaesthesia; elderly; hepatic impairment; psychosis; withdraw gradually.
Possible side effects
Antimuscarinic actions namely: drowsiness; urinary retention; dry mouth; constipation; blurred vision; sweating; hypotensive effect, which may lead to dizziness and syncope. Arrhythmias and heart block; convulsions; haematological and hepatic reactions
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.